Pharmaceutical Chemicals API (267)
Showing 205–216 of 267 products · Page 18 of 23
Revlimid
We can customize according to customer's requirement
Rifabutin
Rifabutin (Rfb) is a bactericidal antibiotic medicine primarily used in the treatment of tuberculosis. The medicine is a semi-synthetic derivative of rifamycin S. Its effect is based on blocking the DNA-dependent RNA-polymerase of the bacteria. It is effective against Gram-positive and some Gram-negative bacteria, but also against the highly resistant mycobacteria, e.g. Mycobacterium tuberculosis, M. leprae, and M. avium intracellulare.
Rifampicin
Rifampicin is typically used to treat Mycobacterium infections, including tuberculosis and leprosy.With multidrug therapy used as the standard treatment of leprosy, rifampicin is always used in combination with dapsone and clofazimine to avoid eliciting drug resistance.
Risperidone
Risperidone is benzisoxazole derivative,a new generation of antipsychotic medicine. The active ingredient of risperidone is a kind of selective monoamine antagonist with unique properties, which has high affinity to 5-HT2 receptor and dopamine D2 receptor of 5. Risperidone can also be combined with alpha 1- adrenergic receptors and binding to H1 receptors and alpha 2- adrenergic receptors with low affinity. Risperidone does not combine with cholinergic receptor. Risperidone is strong D2 antagonists that can improve schizophrenia positive symptoms, but it caused the locomotor inhibition, and catalepsy to less than the classical antipsychotic medicine.
Rivaroxaban
Rivaroxaban (BAY 59-7939) is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is an orally activedirect factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
Ropinirole Hydrochloride API
Ropinirole hydrochloride is DopamineAgonist,it can enhance the effect of dopamine,correct the imbalance of central
Roxithromycin
Roxithromycin is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.Roxithromycin has also been tested to possess antimalarial activity.
Saquinavir Mesylate
Saquinavir mesylate is an antiretroviral drug used together with other medications to treat or prevent HIV/AIDS.
Saracatinib
Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q).
Selumetinib
Smetinib, developed by AstraZeneca, UK, is used to treat advanced non-small cell lung cancer. Smetinib inhibits the growth of a variety of tumors, including melanoma with b-raf-mutation and non-small cell lung cancer with K-ras mutation (NSCLC), mainly by regulating the level of key protein kinase MEK in the RA Raf-MEK-ERK pathway. It is mainly used for the treatment of cholangiocarcinoma, colorectal cancer and NSCLC. At present, smetinib is in the phase III clinical trial of non-small cell lung cancer.
Sitagliptin Phosphate Monohydrate
Acid west his dean was first developed by Merck, Germany won the U.S. food and drug administration approved for the treatment of type 2 diabetes dipeptide base peptidase Ⅳ (DDP - 4) inhibitor medicine, is a new type of diabetes, can increase the body's own ability to reduce high blood sugar levels, inhibit the enzyme activity and relatively improve shortness of naturally occurring intestinal insulin, including sample glucagon peptide 1 promote insulin and glucose dependence peptide levels, increased insulin production is triggering the pancreas and the liver to stop glucose production, and finally the clinical effect of lowering blood sugar concentration. The characteristic of this product is in stimulating insulin secretion, at the same time can reduce hungry feeling, and will not put on weight, also won't hypoglycemia and edema occur, suitable for diabetic patients with poor blood sugar control and frequent hypoglycemia. 552 cases of clinically mild-to-moderate patients with type 2 diabetes, take a daily phosphate west he listed, take 100 milligrams, 12 weeks after can reduce glycated hemoglobin 0.6% - 0.6%
Sorafenib Tosylate
Sorafenib toluene sulfonate is a new multi-target anti-tumor drug, which was developed by Bayer pharmaceutical company in Germany. It can act on tumor cells and tumor blood vessels at the same time. It has dual antitumor effects: it can directly inhibit the proliferation of tumor cells by blocking the Raf / MEK / ERK mediated cell signaling pathway, and it can also block the formation of tumor neovascularization by inhibiting VEGF and PDGF receptor, and indirectly inhibit the growth of tumor cells.
